Search

everythinglearnresearchcommunity

for

Search:↓

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

New genetic factors linked to acne risk were discovered, highlighting the role of certain pathways and genes.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Early hair loss may indicate prostate issues.

Natural products can help overcome cancer drug resistance.

Undariopsis peterseniana extract helps hair grow by activating certain cell growth pathways and could be a new treatment for hair loss.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.